Transcriptome sequencing of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG failure

Authors :: D.K.E. Schoot
Teemu D. Laajala
Ellen C. Zwarthoff
Joost L. Boormans
F.C. De Jong
James C. Costello
Sébastien Rinaldetti
A.C.J. Van Der Made
Egbert R. Boevé
Tahlita C.M. Zuiverloon
Dan Theodorescu
Robert F. Hoedemaeker
Jolien T. M. Mensink
Source :: European Urology. 79:S612-S613
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Basal (phylogenetics)
Bladder cancer
Immune system
business.industry
Urology
medicine
Cancer research
Bcg failure
medicine.disease
business
Transcriptome Sequencing

Full Text Access

Tools